A district consumer court in Uttarakhand on Wednesday found Dr Lal Pathology Lab "grossly negligent" in not providing a report of the first sample and misplacing second sample of a patient who was ...

Jan 30 (Reuters) - India's Dr Lal Path Labs (DLPA.NS), opens new tab reported a 19% jump in its third-quarter profit on Thursday, led by continued demand for its bundle test offerings, sending its ...

April 25 (Reuters) - Dr Lal Path Labs (DLPA.NS), opens new tab, India's largest diagnostics firm by revenue, reported fourth-quarter profit above expectations on Friday as strong demand for its ...

Dr Lal PathLabs Ltd shares dropped sharply in Tuesday's trade amid reports that the Delhi government is set to provide 450 types of medical tests free of cost from January 1. Reports indicated that ...